(NYSE: WAT) Waters's forecast annual revenue growth rate of 4.92% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.63%.
Waters's revenue in 2023 is $2,949,895,000.On average, 5 Wall Street analysts forecast WAT's revenue for 2023 to be $183,867,989,222, with the lowest WAT revenue forecast at $182,265,410,479, and the highest WAT revenue forecast at $184,940,533,581.
In 2024, WAT is forecast to generate $193,338,091,345 in revenue, with the lowest revenue forecast at $191,522,298,815 and the highest revenue forecast at $195,153,883,875.